Switch to:
Also traded in: Austria, Denmark, Germany, Mexico, Switzerland, UK

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash-to-Debt 0.25
CLPBF's Cash-to-Debt is ranked lower than
81% of the 205 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.74 vs. CLPBF: 0.25 )
Ranked among companies with meaningful Cash-to-Debt only.
CLPBF' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.06  Med: 1.06 Max: No Debt
Current: 0.25
0.06
No Debt
Equity-to-Asset 0.41
CLPBF's Equity-to-Asset is ranked lower than
80% of the 196 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.60 vs. CLPBF: 0.41 )
Ranked among companies with meaningful Equity-to-Asset only.
CLPBF' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.33  Med: 0.47 Max: 0.73
Current: 0.41
0.33
0.73
Debt-to-Equity 0.59
CLPBF's Debt-to-Equity is ranked lower than
72% of the 142 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.37 vs. CLPBF: 0.59 )
Ranked among companies with meaningful Debt-to-Equity only.
CLPBF' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.01  Med: 0.31 Max: 1.43
Current: 0.59
0.01
1.43
Debt-to-EBITDA 0.54
CLPBF's Debt-to-EBITDA is ranked higher than
80% of the 109 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.88 vs. CLPBF: 0.54 )
Ranked among companies with meaningful Debt-to-EBITDA only.
CLPBF' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.03  Med: 0.19 Max: 1.89
Current: 0.54
0.03
1.89
Interest Coverage 47.12
CLPBF's Interest Coverage is ranked higher than
63% of the 137 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 63.92 vs. CLPBF: 47.12 )
Ranked among companies with meaningful Interest Coverage only.
CLPBF' s Interest Coverage Range Over the Past 10 Years
Min: 4.9  Med: 55.36 Max: 1382.33
Current: 47.12
4.9
1382.33
Piotroski F-Score: 6
Altman Z-Score: 14.10
Beneish M-Score: -2.62
WACC vs ROIC
6.76%
53.66%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 9/10

vs
industry
vs
history
Operating Margin % 30.84
CLPBF's Operating Margin % is ranked higher than
95% of the 201 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.41 vs. CLPBF: 30.84 )
Ranked among companies with meaningful Operating Margin % only.
CLPBF' s Operating Margin % Range Over the Past 10 Years
Min: 11.75  Med: 30.55 Max: 33.37
Current: 30.84
11.75
33.37
Net Margin % 23.56
CLPBF's Net Margin % is ranked higher than
91% of the 201 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.18 vs. CLPBF: 23.56 )
Ranked among companies with meaningful Net Margin % only.
CLPBF' s Net Margin % Range Over the Past 10 Years
Min: 6.46  Med: 18.56 Max: 24.45
Current: 23.56
6.46
24.45
ROE % 72.83
CLPBF's ROE % is ranked higher than
98% of the 198 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.43 vs. CLPBF: 72.83 )
Ranked among companies with meaningful ROE % only.
CLPBF' s ROE % Range Over the Past 10 Years
Min: 16.36  Med: 40.63 Max: 72.83
Current: 72.83
16.36
72.83
ROA % 30.82
CLPBF's ROA % is ranked higher than
98% of the 206 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.85 vs. CLPBF: 30.82 )
Ranked among companies with meaningful ROA % only.
CLPBF' s ROA % Range Over the Past 10 Years
Min: 8.48  Med: 22.02 Max: 32.94
Current: 30.82
8.48
32.94
ROC (Joel Greenblatt) % 104.98
CLPBF's ROC (Joel Greenblatt) % is ranked higher than
97% of the 204 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.63 vs. CLPBF: 104.98 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
CLPBF' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 27.07  Med: 83.6 Max: 144.25
Current: 104.98
27.07
144.25
3-Year Revenue Growth Rate 7.90
CLPBF's 3-Year Revenue Growth Rate is ranked higher than
64% of the 170 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.10 vs. CLPBF: 7.90 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
CLPBF' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: 3.6  Med: 7.9 Max: 13.4
Current: 7.9
3.6
13.4
3-Year EBITDA Growth Rate 15.60
CLPBF's 3-Year EBITDA Growth Rate is ranked higher than
61% of the 155 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 10.00 vs. CLPBF: 15.60 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
CLPBF' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -21.2  Med: 15.4 Max: 23.6
Current: 15.6
-21.2
23.6
3-Year EPS without NRI Growth Rate 16.90
CLPBF's 3-Year EPS without NRI Growth Rate is ranked higher than
59% of the 155 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 12.90 vs. CLPBF: 16.90 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
CLPBF' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -25.8  Med: 10.1 Max: 53.6
Current: 16.9
-25.8
53.6
GuruFocus has detected 2 Warning Signs with Coloplast A/S CLPBF.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» CLPBF's 30-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Insider Trades

Latest Guru Trades with OTCPK:CLPBF

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

Guru Date Action
Impact Price Range
(Average)*
Change from Average Comment Current Shares
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies    NAICS: 334510 
Compare:TSE:4543, NYSE:WAT, NYSE:MTD, NYSE:RMD, TSE:7733, NAS:XRAY, NYSE:COO, XSWX:STMN, NAS:HOLX, NYSE:STE, SZSE:002294, NYSE:WST, XPAR:EI, NYSE:HRC, NAS:ICUI, NAS:PODD, NYSE:CMD, TSE:7747, NYSE:HAE, MIL:AMP » details
Traded in other countries:COLO.Austria, COLO B.Denmark, CBHD.Germany, 0QBO N.Mexico, COLOB.Switzerland, 0QBO.UK,
Headquarter Location:Denmark
Coloplast A/S develops and markets products and services that make life easier for people with private and personal medical conditions. The company supplies its products to hospitals, institutions as well as wholesalers and pharmacies.

Coloplast is a leading competitor in ostomy management and continence care. The firm designs, manufactures, and markets ostomy-care systems, disposable containment devices, paste, powder, seals, and wipes. Coloplast also maintains a tertiary presence in the urology and wound-care markets, where it manufactures and markets penile implants, slings for incontinence and prolapse, and wound dressings. The company derives more than 66% of sales from Europe, 20% from North and South America, and 14% from the rest of the world.

Ratios

vs
industry
vs
history
PE Ratio 34.46
CLPBF's PE Ratio is ranked higher than
59% of the 125 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 31.70 vs. CLPBF: 34.46 )
Ranked among companies with meaningful PE Ratio only.
CLPBF' s PE Ratio Range Over the Past 10 Years
Min: 12.11  Med: 27.84 Max: 135.36
Current: 34.46
12.11
135.36
Forward PE Ratio 29.59
CLPBF's Forward PE Ratio is ranked lower than
55% of the 40 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 26.32 vs. CLPBF: 29.59 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 34.46
CLPBF's PE Ratio without NRI is ranked higher than
62% of the 123 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9999.00 vs. CLPBF: 34.46 )
Ranked among companies with meaningful PE Ratio without NRI only.
CLPBF' s PE Ratio without NRI Range Over the Past 10 Years
Min: 11.95  Med: 27.84 Max: 135.36
Current: 34.46
11.95
135.36
Price-to-Owner-Earnings 38.62
CLPBF's Price-to-Owner-Earnings is ranked lower than
55% of the 83 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 30.92 vs. CLPBF: 38.62 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
CLPBF' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 20.42  Med: 35.18 Max: 80.53
Current: 38.62
20.42
80.53
PB Ratio 25.19
CLPBF's PB Ratio is ranked lower than
97% of the 193 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.45 vs. CLPBF: 25.19 )
Ranked among companies with meaningful PB Ratio only.
CLPBF' s PB Ratio Range Over the Past 10 Years
Min: 5.78  Med: 15.76 Max: 29.53
Current: 25.19
5.78
29.53
PS Ratio 8.12
CLPBF's PS Ratio is ranked lower than
75% of the 192 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.48 vs. CLPBF: 8.12 )
Ranked among companies with meaningful PS Ratio only.
CLPBF' s PS Ratio Range Over the Past 10 Years
Min: 1.95  Med: 6.64 Max: 9.35
Current: 8.12
1.95
9.35
Price-to-Free-Cash-Flow 36.67
CLPBF's Price-to-Free-Cash-Flow is ranked lower than
58% of the 74 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 28.61 vs. CLPBF: 36.67 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
CLPBF' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 11.51  Med: 32.46 Max: 102.03
Current: 36.67
11.51
102.03
Price-to-Operating-Cash-Flow 30.10
CLPBF's Price-to-Operating-Cash-Flow is ranked lower than
64% of the 94 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 21.15 vs. CLPBF: 30.10 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
CLPBF' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 9.05  Med: 26.7 Max: 49.74
Current: 30.1
9.05
49.74
EV-to-EBIT 26.68
CLPBF's EV-to-EBIT is ranked higher than
57% of the 121 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 23.93 vs. CLPBF: 26.68 )
Ranked among companies with meaningful EV-to-EBIT only.
CLPBF' s EV-to-EBIT Range Over the Past 10 Years
Min: 11.3  Med: 21.7 Max: 81.6
Current: 26.68
11.3
81.6
EV-to-EBITDA 23.74
CLPBF's EV-to-EBITDA is ranked lower than
51% of the 138 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 19.49 vs. CLPBF: 23.74 )
Ranked among companies with meaningful EV-to-EBITDA only.
CLPBF' s EV-to-EBITDA Range Over the Past 10 Years
Min: 8.2  Med: 18.95 Max: 61.2
Current: 23.74
8.2
61.2
EV-to-Revenue 8.37
CLPBF's EV-to-Revenue is ranked lower than
77% of the 199 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.57 vs. CLPBF: 8.37 )
Ranked among companies with meaningful EV-to-Revenue only.
CLPBF' s EV-to-Revenue Range Over the Past 10 Years
Min: 1.9  Med: 6.7 Max: 9.5
Current: 8.37
1.9
9.5
PEG Ratio 6.30
CLPBF's PEG Ratio is ranked lower than
80% of the 69 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.70 vs. CLPBF: 6.30 )
Ranked among companies with meaningful PEG Ratio only.
CLPBF' s PEG Ratio Range Over the Past 10 Years
Min: 0.65  Med: 3.13 Max: 309.31
Current: 6.3
0.65
309.31
Shiller PE Ratio 54.21
CLPBF's Shiller PE Ratio is ranked higher than
67% of the 54 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 50.97 vs. CLPBF: 54.21 )
Ranked among companies with meaningful Shiller PE Ratio only.
CLPBF' s Shiller PE Ratio Range Over the Past 10 Years
Min: 38.96  Med: 54.05 Max: 62.58
Current: 54.21
38.96
62.58
Current Ratio 0.96
CLPBF's Current Ratio is ranked lower than
91% of the 200 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.57 vs. CLPBF: 0.96 )
Ranked among companies with meaningful Current Ratio only.
CLPBF' s Current Ratio Range Over the Past 10 Years
Min: 0.84  Med: 1.62 Max: 2.93
Current: 0.96
0.84
2.93
Quick Ratio 0.71
CLPBF's Quick Ratio is ranked lower than
90% of the 201 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.87 vs. CLPBF: 0.71 )
Ranked among companies with meaningful Quick Ratio only.
CLPBF' s Quick Ratio Range Over the Past 10 Years
Min: 0.64  Med: 1.16 Max: 2.39
Current: 0.71
0.64
2.39
Days Inventory 116.62
CLPBF's Days Inventory is ranked higher than
51% of the 197 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 124.35 vs. CLPBF: 116.62 )
Ranked among companies with meaningful Days Inventory only.
CLPBF' s Days Inventory Range Over the Past 10 Years
Min: 96.12  Med: 110.34 Max: 118.18
Current: 116.62
96.12
118.18
Days Sales Outstanding 66.94
CLPBF's Days Sales Outstanding is ranked lower than
52% of the 165 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 61.97 vs. CLPBF: 66.94 )
Ranked among companies with meaningful Days Sales Outstanding only.
CLPBF' s Days Sales Outstanding Range Over the Past 10 Years
Min: 61.8  Med: 64.91 Max: 67.93
Current: 66.94
61.8
67.93
Days Payable 45.32
CLPBF's Days Payable is ranked lower than
66% of the 151 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 54.66 vs. CLPBF: 45.32 )
Ranked among companies with meaningful Days Payable only.
CLPBF' s Days Payable Range Over the Past 10 Years
Min: 40.48  Med: 46.21 Max: 54.72
Current: 45.32
40.48
54.72

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield % 2.63
CLPBF's Dividend Yield % is ranked higher than
90% of the 164 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.16 vs. CLPBF: 2.63 )
Ranked among companies with meaningful Dividend Yield % only.
CLPBF' s Dividend Yield % Range Over the Past 10 Years
Min: 0.89  Med: 2.19 Max: 3.1
Current: 2.63
0.89
3.1
Dividend Payout Ratio 0.86
CLPBF's Dividend Payout Ratio is ranked higher than
61% of the 100 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.31 vs. CLPBF: 0.86 )
Ranked among companies with meaningful Dividend Payout Ratio only.
CLPBF' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.23  Med: 0.56 Max: 2.86
Current: 0.86
0.23
2.86
3-Year Dividend Growth Rate 5.50
CLPBF's 3-Year Dividend Growth Rate is ranked lower than
65% of the 62 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.90 vs. CLPBF: 5.50 )
Ranked among companies with meaningful 3-Year Dividend Growth Rate only.
CLPBF' s 3-Year Dividend Growth Rate Range Over the Past 10 Years
Min: 3.6  Med: 20.5 Max: 79.2
Current: 5.5
3.6
79.2
Forward Dividend Yield % 2.63
CLPBF's Forward Dividend Yield % is ranked higher than
93% of the 161 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.30 vs. CLPBF: 2.63 )
Ranked among companies with meaningful Forward Dividend Yield % only.
N/A
5-Year Yield-on-Cost % 10.42
CLPBF's 5-Year Yield-on-Cost % is ranked higher than
96% of the 209 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.44 vs. CLPBF: 10.42 )
Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
CLPBF' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 3.53  Med: 8.68 Max: 12.28
Current: 10.42
3.53
12.28
3-Year Average Share Buyback Ratio -0.30
CLPBF's 3-Year Average Share Buyback Ratio is ranked higher than
80% of the 143 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: -5.00 vs. CLPBF: -0.30 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
CLPBF' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -2.9  Med: 0.1 Max: 5.8
Current: -0.3
-2.9
5.8

Valuation & Return

vs
industry
vs
history
Price-to-Tangible-Book 48.93
CLPBF's Price-to-Tangible-Book is ranked lower than
98% of the 167 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.77 vs. CLPBF: 48.93 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
CLPBF' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 8.05  Med: 20.99 Max: 59.96
Current: 48.93
8.05
59.96
Price-to-Intrinsic-Value-Projected-FCF 4.11
CLPBF's Price-to-Intrinsic-Value-Projected-FCF is ranked lower than
64% of the 75 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.41 vs. CLPBF: 4.11 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
CLPBF' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 3.02  Med: 3.62 Max: 4.72
Current: 4.11
3.02
4.72
Price-to-Intrinsic-Value-DCF (Earnings Based) 1.23
CLPBF's Price-to-Intrinsic-Value-DCF (Earnings Based) is ranked higher than
96% of the 23 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.20 vs. CLPBF: 1.23 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-DCF (Earnings Based) only.
CLPBF' s Price-to-Intrinsic-Value-DCF (Earnings Based) Range Over the Past 10 Years
Min: 0.97  Med: 1.25 Max: 5.58
Current: 1.23
0.97
5.58
Price-to-Median-PS-Value 1.22
CLPBF's Price-to-Median-PS-Value is ranked higher than
51% of the 160 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.13 vs. CLPBF: 1.22 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
CLPBF' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.31  Med: 0.99 Max: 1.31
Current: 1.22
0.31
1.31
Price-to-Peter-Lynch-Fair-Value 4.17
CLPBF's Price-to-Peter-Lynch-Fair-Value is ranked lower than
99.99% of the 45 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.46 vs. CLPBF: 4.17 )
Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.
CLPBF' s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 1  Med: 2.66 Max: 21.64
Current: 4.17
1
21.64
Price-to-Graham-Number 8.67
CLPBF's Price-to-Graham-Number is ranked lower than
96% of the 94 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.77 vs. CLPBF: 8.67 )
Ranked among companies with meaningful Price-to-Graham-Number only.
CLPBF' s Price-to-Graham-Number Range Over the Past 10 Years
Min: 2.74  Med: 5.11 Max: 16.37
Current: 8.67
2.74
16.37
Earnings Yield (Greenblatt) % 3.75
CLPBF's Earnings Yield (Greenblatt) % is ranked higher than
75% of the 207 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.40 vs. CLPBF: 3.75 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
CLPBF' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 1.2  Med: 4.6 Max: 8.9
Current: 3.75
1.2
8.9
Forward Rate of Return (Yacktman) % 10.29
CLPBF's Forward Rate of Return (Yacktman) % is ranked lower than
64% of the 101 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.66 vs. CLPBF: 10.29 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
CLPBF' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: -4  Med: 10.2 Max: 24.1
Current: 10.29
-4
24.1

More Statistics

Revenue (TTM) (Mil) $2,596.58
EPS (TTM) $ 2.88
Beta0.99
Volatility25.06%
52-Week Range $77.50 - 112.43
Shares Outstanding (Mil)211.86

Analyst Estimate

Sep18 Sep19 Sep20
Revenue (Mil $) 2,578 2,781 3,077
EBIT (Mil $) 792 882 980
EBITDA (Mil $) 885 982 1,094
EPS ($) 2.82 3.16 3.56
EPS without NRI ($) 2.82 3.16 3.56
EPS Growth Rate
(Future 3Y To 5Y Estimate)
12.01%
Dividends per Share ($) 2.02 2.14 2.66

Piotroski F-Score Details

Piotroski F-Score: 66
Positive ROAY
Positive CFROAY
Higher ROA yoyY
CFROA > ROAY
Lower Leverage yoyN
Higher Current Ratio yoyY
Less Shares Outstanding yoyY
Higher Gross Margin yoyN
Higher Asset Turnover yoyN

» More Articles for OTCPK:CLPBF

Headlines

Articles On GuruFocus.com

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}